The Journal.The Wall Street Journal & Spotify Studios
- 0 Anmeldelser
- 0
- Episode
- 1729 of 1926
- Længde
- 18M
- Sprog
- Engelsk
- Format
- Kategori
- Økonomi & Business
A CNBC investigation into counterfeit weight loss drugs revealed an international illegal marketplace where criminals either brazenly alter the drugs or ship the real product from overseas — what’s known as drug diversion and against federal law.
The operations mainly involve phony or illegal versions of Novo Nordisk’s diabetes drug Ozempic and its obesity drug Wegovy as well as Eli Lilly’s Mounjaro and Zepbound. All four drugs are in a class of wildly popular weight loss drugs known as GLP-1s. The skyrocketing demand for the treatments has led to criminal schemes attempting to capitalize on the surge.
To view the documentary and read the full article go to https://cnb.cx/3NfQO8V
Lyt når som helst, hvor som helst
Nyd den ubegrænsede adgang til tusindvis af spændende e- og lydbøger - helt gratis
- Lyt og læs så meget du har lyst til
- Opdag et kæmpe bibliotek fyldt med fortællinger
- Eksklusive titler + Mofibo Originals
- Opsig når som helst
Other podcasts you might like ...
- Redefining CyberSecuritySean Martin
- Maxwell Leadership Executive PodcastJohn Maxwell
- Ruby RoguesCharles M Wood
- EGO NetCastMartin Lindeskog
- Pitchfork Economics with Nick HanauerCivic Ventures
- The Pathless Path with Paul MillerdPaul Millerd
- SvD LedarredaktionenSvenska Dagbladet
- WorkLife with Adam GrantTED
- Goldman Sachs ExchangesGoldman Sachs
- The Journal.The Wall Street Journal & Spotify Studios
- Redefining CyberSecuritySean Martin
- Maxwell Leadership Executive PodcastJohn Maxwell
- Ruby RoguesCharles M Wood
- EGO NetCastMartin Lindeskog
- Pitchfork Economics with Nick HanauerCivic Ventures
- The Pathless Path with Paul MillerdPaul Millerd
- SvD LedarredaktionenSvenska Dagbladet
- WorkLife with Adam GrantTED
- Goldman Sachs ExchangesGoldman Sachs
Sprog og region
Dansk
Danmark
